Becoming a medical device distributor involves more than securing a supply agreement; it requires building the regulatory, logistical, and clinical support infrastructure needed to bring devices into a market safely and sustainably. Companies exploring distributorship — whether entering the medical device sector for the first time or expanding an existing distribution business into a new device category — typically move through a sequence of steps covering regulatory registration, territory negotiation, and demonstrating the operational capability a manufacturer looks for in a long-term partner. This roadmap outlines the major stages involved.
What Regulatory Steps Come Before Distribution Can Begin?
Before distributing medical devices in a given country, a distributor generally needs to establish the appropriate regulatory registration for that market, which varies significantly by jurisdiction. In the European Union, this involves ensuring devices carry valid European market authorization under the applicable European medical device regulations and that the distributor understands its own obligations under the regulation, which include verifying the manufacturer's certification, checking device labeling and Instructions for Use (IFU) compliance, and maintaining traceability records. In the United States, device distribution typically requires working with or becoming an registered with the U.S. authority as entity, a status distinct from the U.S. regulatory authority device approval; a distributor's own registration confirms the company is listed with the U.S. regulatory authority, not that a specific device has received US regulatory clearance. Understanding these regulatory obligations early avoids delays once a distribution agreement is in place.
How Do Manufacturers Evaluate Potential Distribution Partners?
Manufacturers typically assess prospective distributors on several dimensions: existing relationships with target hospitals or clinics, technical and clinical support capability (since many interventional devices require in-servicing or case support), warehousing and logistics infrastructure suited to sterile medical products, and financial stability to sustain inventory investment. A distributor demonstrating clinical knowledge of the relevant specialty — for example, interventional cardiology or vascular device categories — is often viewed favorably, since manufacturers rely on distributors to represent devices accurately to clinicians and to provide credible field support after the sale.
What Do Territory Rights Typically Cover?
Distribution agreements commonly define an exclusive or non-exclusive territory, minimum purchase or sales commitments tied to maintaining exclusivity, and the scope of device categories included in the arrangement. Territory definitions can be geographic (a country or region) or channel-based (a specific hospital network or care setting), and manufacturers often build in performance review periods to reassess the relationship as the distributor's market presence develops. Distributors should clarify these terms in writing before investing significantly in market entry activities, since ambiguity around territory scope is a common source of later disputes between manufacturer and distributor.
How Can a Prospective Distributor Approach a Manufacturer Like INVAMED?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
What clinical support capabilities do manufacturers expect from distributors?
Manufacturers commonly look for distributors able to provide in-service training, case support, and responsive technical assistance to clinicians using the device, particularly for interventional or surgical products with a learning curve. Demonstrating this capability, even through partnerships or hires, can strengthen a distributorship proposal.